Skip to main content

2020 | OriginalPaper | Buchkapitel

Patient Stratification Using Clinical and Patient Profiles: Targeting Personalized Prognostic Prediction in ALS

verfasst von : Sofia Pires, Marta Gromicho, Susana Pinto, Mamede de Carvalho, Sara C. Madeira

Erschienen in: Bioinformatics and Biomedical Engineering

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a severe neurodegenerative disease with highly heterogeneous disease presentation and progression patterns. This hampers effective treatments targeting all patients and finding a cure is still a challenge. In this scenario, patient stratification is believed to be a key tool to deal with the heterogeneous nature of the disease, promoting the discovery of more homogeneous groups of patients, that can then be used to improve patient prognosis and care. In this work, we propose to use clustering to stratify patient observations in accordance with clinically defined subsets of features (Clinical Profiles). The groups obtained by clustering patients using the Clinical Profiles are called Patient Profiles. Each patient profile is then used to learn specialized prognostic models to predict the need for Non-Invasive Ventilation (NIV) within a time window of 90 days. Each patient profile specific prognostic model is then used in ensemble learning. We used three clinical profiles (prognostic, respiratory and functional) based on complementary clinically relevant views of disease presentation and progression. These clinical profiles yielded two, four, and two patient profiles, respectively. The specialized prognostic models learned from these clinical and patient profiles show overall improvements when compared to the baseline models, where patients are not stratified. These promising results highlight the need for patient stratification for prognostic prediction in ALS. Furthermore, this innovative approach for prognostic prediction, where clinical profiles and patient profiles are integrated to enhance patient stratification, can be used to improve predictions for other disease outcomes in ALS or applied to other diseases.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Pires, S., Gromicho, M.: Predicting non-invasive ventilation in ALS patients using stratified disease progression groups. In: 2018 IEEE International Conference Data Mining Workshops, pp. 748–757 (2018) Pires, S., Gromicho, M.: Predicting non-invasive ventilation in ALS patients using stratified disease progression groups. In: 2018 IEEE International Conference Data Mining Workshops, pp. 748–757 (2018)
2.
Zurück zum Zitat Lechtzin, N., et al.: Respiratory measures in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 19(5–6), 1–10 (2018) Lechtzin, N., et al.: Respiratory measures in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 19(5–6), 1–10 (2018)
3.
Zurück zum Zitat Grollemund, V., Pradat, P., Querin, G., Delbot, F.: Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front. Neurosci. 13, 1–28 (2019)CrossRef Grollemund, V., Pradat, P., Querin, G., Delbot, F.: Machine learning in amyotrophic lateral sclerosis: achievements, pitfalls, and future directions. Front. Neurosci. 13, 1–28 (2019)CrossRef
4.
Zurück zum Zitat Fang, T., et al.: Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 17(5), 416–422 (2018)CrossRef Fang, T., et al.: Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 17(5), 416–422 (2018)CrossRef
5.
Zurück zum Zitat Bourke, S.C., Tomlinson, M., Williams, T.L., Bullock, R.E., Shaw, P.J., Gibson, G.J.: Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 5(2), 140–147 (2006)CrossRef Bourke, S.C., Tomlinson, M., Williams, T.L., Bullock, R.E., Shaw, P.J., Gibson, G.J.: Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 5(2), 140–147 (2006)CrossRef
6.
Zurück zum Zitat Westeneng, H.J., et al.: Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 17(5), 423–433 (2018)CrossRef Westeneng, H.J., et al.: Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 17(5), 423–433 (2018)CrossRef
7.
Zurück zum Zitat Pfohl, S.R., Kim, R.B., Coan, G.S., Mitchell, C.S.: Unraveling the complexity of amyotrophic lateral sclerosis survival prediction. Front. Neuroinform. 12(36), 36 (2018)CrossRef Pfohl, S.R., Kim, R.B., Coan, G.S., Mitchell, C.S.: Unraveling the complexity of amyotrophic lateral sclerosis survival prediction. Front. Neuroinform. 12(36), 36 (2018)CrossRef
8.
Zurück zum Zitat van Es, M.A., et al.: Amyotrophic lateral sclerosis. Lancet 390(10107), 2084–2098 (2017)CrossRef van Es, M.A., et al.: Amyotrophic lateral sclerosis. Lancet 390(10107), 2084–2098 (2017)CrossRef
9.
Zurück zum Zitat Carreiro, A.V., Amaral, P.M.T., Pinto, S., Tomás, P., de Carvalho, M., Madeira, S.C.: Prognostic models based on patient snapshots and time windows: predicting disease progression to assisted ventilation in Amyotrophic Lateral Sclerosis. J. Biomed. Inform. 58, 133–144 (2015)CrossRef Carreiro, A.V., Amaral, P.M.T., Pinto, S., Tomás, P., de Carvalho, M., Madeira, S.C.: Prognostic models based on patient snapshots and time windows: predicting disease progression to assisted ventilation in Amyotrophic Lateral Sclerosis. J. Biomed. Inform. 58, 133–144 (2015)CrossRef
10.
Zurück zum Zitat Martin, S., Al Khleifat, A., Al-Chalabi, A.: What causes amyotrophic lateral sclerosis? F1000Research 6, 371 (2017)CrossRef Martin, S., Al Khleifat, A., Al-Chalabi, A.: What causes amyotrophic lateral sclerosis? F1000Research 6, 371 (2017)CrossRef
11.
Zurück zum Zitat Do, C.B., Batzoglou, S.: What is the expectation maximization algorithm? Nat. Biotechnol. 26(8), 897–899 (2008)CrossRef Do, C.B., Batzoglou, S.: What is the expectation maximization algorithm? Nat. Biotechnol. 26(8), 897–899 (2008)CrossRef
12.
Zurück zum Zitat Rousseeuw, P.J.: Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53–65 (1987)CrossRef Rousseeuw, P.J.: Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53–65 (1987)CrossRef
13.
Zurück zum Zitat He, H., Garcia, E.A.: Learning from imbalanced data. IEEE Trans. Knowl. Data Eng. 21(9), 1263–1284 (2009)CrossRef He, H., Garcia, E.A.: Learning from imbalanced data. IEEE Trans. Knowl. Data Eng. 21(9), 1263–1284 (2009)CrossRef
14.
Zurück zum Zitat Chawla, N.V., Bowyer, K.W., Hall, L.O., Kegelmeyer, W.P.: SMOTE: synthetic minority over-sampling technique. J. Artif. Intell. Res. 16, 321–357 (2002)CrossRef Chawla, N.V., Bowyer, K.W., Hall, L.O., Kegelmeyer, W.P.: SMOTE: synthetic minority over-sampling technique. J. Artif. Intell. Res. 16, 321–357 (2002)CrossRef
Metadaten
Titel
Patient Stratification Using Clinical and Patient Profiles: Targeting Personalized Prognostic Prediction in ALS
verfasst von
Sofia Pires
Marta Gromicho
Susana Pinto
Mamede de Carvalho
Sara C. Madeira
Copyright-Jahr
2020
DOI
https://doi.org/10.1007/978-3-030-45385-5_47